ProPhase Labs, Inc.
PRPH
Rank in Stocks
#34079
ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously... ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services. Through its Consumer Products division, ProPhase Labs is actively involved in the entire process—from researching and developing to manufacturing, distributing, marketing, and selling—a range of over-the-counter (OTC) healthcare items and nutritional supplements within the United States. Notable offerings include dietary supplements like Legendz XL, which supports male sexual health, and Triple Edge XL, formulated to enhance energy and stamina. The Diagnostic Services segment provides crucial testing solutions, including PCR tests for SARS-CoV-2 (COVID-19) and its variant mutations, using both saliva and nasal swab collection methods. This segment also offers molecular testing for other respiratory pathogens and supplies personal genomics products and services. Additionally, ProPhase Labs extends its capabilities by providing comprehensive contract manufacturing services, covering product development, pre-commercialization activities, production, warehousing, and distribution. The company's diverse products and services reach consumers through a broad network of national chain drug stores, various regional retailers, and online platforms.
Share Price
$0.005525
Last synced: 2026-11-09
Market Cap
$77.44K
Change (1 day)
-44.75%
Change (1 year)
-99.80%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade ProPhase Labs, Inc. (PRPH)
Category
Healthcare
Dividend history for ProPhase Labs, Inc. (PRPH)
ProPhase Labs, Inc. (stock symbol: PRPH) made a total of 7 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $3.40
Dividend yield (TTM) : 0.00%
The sum of all dividends (adjusted for stock splits) is : $3.40
Dividend yield (TTM) : 0.00%
Dividend payments for ProPhase Labs, Inc. (PRPH) from 2018 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $0.6 | 0.00% |
| 2022 | $0.6 | 100.00% |
| 2021 | $0.3 | -40.00% |
| 2019 | $0.5 | -75.00% |
| 2018 | $2.00 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $6.00 | 0.00% |
| 2022 | $6.00 | 100.00% |
| 2021 | $3.00 | -40.00% |
| 2019 | $5.00 | -54.55% |
| 2018 | $11.00 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 13.00% |
DE
|
|
| 26.00% |
DE
|
|
| 55.00% |
JP
|
|
| 2.00% |
CH
|
|
| 62.00% |
IL
|
Questions about ProPhase Labs, Inc.'s dividend per share
What is ProPhase Labs, Inc.'s dividend per share?
ProPhase Labs, Inc.'s dividend per share over the last twelve months is $0.60, as of May 2022.
What was ProPhase Labs, Inc.'s dividend per share in 2022?
In 2022, ProPhase Labs, Inc.'s dividend per share was $0.60, 100.00% more than in 2021 ($0.30).
How has ProPhase Labs, Inc.'s dividend per share changed since 2018?
From 2018 to 2022, ProPhase Labs, Inc.'s dividend per share went from $2.00 to $0.60, an average decline of 25.99% a year.